We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Patient Package Insert Regulations Stayed

William R. Barclay, MD
JAMA. 1981;246(3):252. doi:10.1001/jama.1981.03320030044029.
Text Size: A A A
Published online


On April 28, 1981, a notice from the Food and Drug Administration published in the Federal Register stayed the effective date of final regulations that would mandate patient package inserts for ampicillin, amoxicillin, hetacillin, cimetidine, clofibrate, phenytoin, and propoxyphene drugs. This stay does not affect requirements for patient package inserts for the oral contraceptive estrogen, and progestational drugs codified earlier in the Federal Register. This stay is welcome, even though it may defer action only until July 1, 1981, for it gives more time to explore the necessity for, and the cost and potential usefulness of, patient package inserts.

Under ideal circumstances, government agencies should not intervene between patient and physician, with mandates concerning diagnosis or treatment. Unfortunately, circumstances are not always ideal; and some patients receive prescriptions from their physician for medications about which the patient has no knowledge and has received no instruction. Some physicians do not put


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.